Post Archive
-
Etcembly reveals world’s first immunotherapy drug designed using generative AI technology
-
New ‘out of this world’ conference centre opens at Harwell
-
Harwell Green Week 2023 highlights
-
UKAEA and Oxford Sigma collaborate to help demonstrate the commercial viability of fusion energy
-
NQCC announces £30 million of investment
-
Nucleic Acid Therapies have the potential to transform health
-
Harwell secures £300m new funding for next phase of campus development
-
UK ‘knitted satellite’ will see Earth day or night
-
Moderna selects Harwell as UK home
-
Astroscale wins Dstl funding for exploration of future Space-Based missions